Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohno

Showing results (371-380 of 400) with videos related to

Pageof 40
Sort By:
British Journal of Haematology|January 29, 2000
Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study GroupA Takeshita, K Shinjo, M Higuchi, et al.
Leukemia|January 19, 2000
Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemiaT Yokozawa, M Towatari, H Iida, et al.
Leukemia|September 20, 2000
In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity and reduction in WT1 gene expressionL Pan, K Ohnishi, W J Zhang, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remissionH Oh, R P Gale, M J Zhang, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1979
[Treatment of infection in the patients of acute leukemia with sulfamethoxazole-trimethoprim (author's transl)]K Ezaki, R Ohno, T Kamiya, et al.
Leukemia|October 17, 2003
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtypeN Matsuno, M Osato, N Yamashita, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignanciesR Ohno, Y Yamaguchi, T Toge, et al.
Blood|April 27, 1999
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemiaH Kiyoi, T Naoe, Y Nakano, et al.
Pageof 40

Showing results (371-380 of 400) with videos related to

Sort By:
Pageof 40
British Journal of Haematology|January 29, 2000
Quantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study GroupA Takeshita, K Shinjo, M Higuchi, et al.
Leukemia|January 19, 2000
Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemiaT Yokozawa, M Towatari, H Iida, et al.
Leukemia|September 20, 2000
In vitro IL-12 treatment of peripheral blood mononuclear cells from patients with leukemia or myelodysplastic syndromes: increase in cytotoxicity and reduction in WT1 gene expressionL Pan, K Ohnishi, W J Zhang, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remissionH Oh, R P Gale, M J Zhang, et al.
European Journal of Haematology|July 29, 2000
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1979
[Treatment of infection in the patients of acute leukemia with sulfamethoxazole-trimethoprim (author's transl)]K Ezaki, R Ohno, T Kamiya, et al.
Leukemia|October 17, 2003
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtypeN Matsuno, M Osato, N Yamashita, et al.
Leukemia|February 13, 2002
Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyT Naoe, Y Tagawa, H Kiyoi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignanciesR Ohno, Y Yamaguchi, T Toge, et al.
Blood|April 27, 1999
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemiaH Kiyoi, T Naoe, Y Nakano, et al.
Pageof 40